Efficacy of attention bias modification training for depressed adults: a randomized clinical trial. 2021

Kean J Hsu, and Jason Shumake, and Kayla Caffey, and Semeon Risom, and Jocelyn Labrada, and Jasper A J Smits, and David M Schnyer, and Christopher G Beevers
Georgetown University Medical Center, Washington, DC, USA.

BACKGROUND This study examined the efficacy of attention bias modification training (ABMT) for the treatment of depression. METHODS In this randomized clinical trial, 145 adults (77% female, 62% white) with at least moderate depression severity [i.e. self-reported Quick Inventory of Depressive Symptomatology (QIDS-SR) ⩾13] and a negative attention bias were randomized to active ABMT, sham ABMT, or assessments only. The training consisted of two in-clinic and three (brief) at-home ABMT sessions per week for 4 weeks (2224 training trials total). The pre-registered primary outcome was change in QIDS-SR. Secondary outcomes were the 17-item Hamilton Depression Rating Scale (HRSD) and anhedonic depression and anxious arousal from the Mood and Anxiety Symptom Questionnaire (MASQ). Primary and secondary outcomes were administered at baseline and four weekly assessments during ABMT. RESULTS Intent-to-treat analyses indicated that, relative to assessment-only, active ABMT significantly reduced QIDS-SR and HRSD scores by an additional 0.62 ± 0.23 (p = 0.008, d = -0.57) and 0.74 ± 0.31 (p = 0.021, d = -0.49) points per week. Similar results were observed for active v. sham ABMT: a greater symptom reduction of 0.44 ± 0.24 QIDS-SR (p = 0.067, d = -0.41) and 0.69 ± 0.32 HRSD (p = 0.033, d = -0.42) points per week. Sham ABMT did not significantly differ from the assessment-only condition. No significant differences were observed for the MASQ scales. CONCLUSIONS Depressed individuals with at least modest negative attentional bias benefitted from active ABMT.

UI MeSH Term Description Entries

Related Publications

Kean J Hsu, and Jason Shumake, and Kayla Caffey, and Semeon Risom, and Jocelyn Labrada, and Jasper A J Smits, and David M Schnyer, and Christopher G Beevers
September 2016, Behaviour research and therapy,
Kean J Hsu, and Jason Shumake, and Kayla Caffey, and Semeon Risom, and Jocelyn Labrada, and Jasper A J Smits, and David M Schnyer, and Christopher G Beevers
October 2019, Psychological medicine,
Kean J Hsu, and Jason Shumake, and Kayla Caffey, and Semeon Risom, and Jocelyn Labrada, and Jasper A J Smits, and David M Schnyer, and Christopher G Beevers
April 2019, Child psychiatry and human development,
Kean J Hsu, and Jason Shumake, and Kayla Caffey, and Semeon Risom, and Jocelyn Labrada, and Jasper A J Smits, and David M Schnyer, and Christopher G Beevers
February 2018, Pain,
Kean J Hsu, and Jason Shumake, and Kayla Caffey, and Semeon Risom, and Jocelyn Labrada, and Jasper A J Smits, and David M Schnyer, and Christopher G Beevers
August 2019, BMC psychiatry,
Kean J Hsu, and Jason Shumake, and Kayla Caffey, and Semeon Risom, and Jocelyn Labrada, and Jasper A J Smits, and David M Schnyer, and Christopher G Beevers
December 2015, Journal of behavior therapy and experimental psychiatry,
Kean J Hsu, and Jason Shumake, and Kayla Caffey, and Semeon Risom, and Jocelyn Labrada, and Jasper A J Smits, and David M Schnyer, and Christopher G Beevers
June 2018, Journal of behavior therapy and experimental psychiatry,
Kean J Hsu, and Jason Shumake, and Kayla Caffey, and Semeon Risom, and Jocelyn Labrada, and Jasper A J Smits, and David M Schnyer, and Christopher G Beevers
July 2015, Social cognitive and affective neuroscience,
Kean J Hsu, and Jason Shumake, and Kayla Caffey, and Semeon Risom, and Jocelyn Labrada, and Jasper A J Smits, and David M Schnyer, and Christopher G Beevers
January 2024, Journal of anxiety disorders,
Kean J Hsu, and Jason Shumake, and Kayla Caffey, and Semeon Risom, and Jocelyn Labrada, and Jasper A J Smits, and David M Schnyer, and Christopher G Beevers
May 2021, Journal of consulting and clinical psychology,
Copied contents to your clipboard!